Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open-Label Study of Pharmacokinetics, Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Patients With Hypo- or Agammaglobulinemia

NCT00161993 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT00161993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open-Label Study of Pharmacokinetics, Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Patients With Hypo- or Agammaglobulinemia
Lead sponsor
Baxalta now part of Shire
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2002
Completion date
September 24, 2003
Enrollment
24 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

agammaglobulinemia, hypogammaglobulinemia, primary immunodeficiency diseases (pid)